Syndax Pharmaceuticals Inc short interest in 2026
In 2026, Syndax Pharmaceuticals Inc's disclosed short interest ran from 25.71% of shares outstanding on 15 Jan 2026 to 23.14% on 15 Sep 2026, a change of -2.57 percentage points. The year's high was 25.71% on 15 Jan 2026 and its low 18.78% on 29 May 2026, averaging 23.93% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.86 days on 27 Feb 2026. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 25.71% (15 Jan 2026)
- End of year
- 23.14% (15 Sep 2026)
- Change
- -2.57 pp
- High
- 25.71% (15 Jan 2026)
- Low
- 18.78% (29 May 2026)
- Average
- 23.93%
- Highest days to cover
- 19.86 (27 Feb 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 25.71% | 16.06 | results (8-K) |
| 30 Jan 2026 | 24.33% | 17.22 | |
| 13 Feb 2026 | 25.45% | 17.85 | |
| 27 Feb 2026 | 25.08% | 19.86 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 23.57% | 13.48 | |
| 31 Mar 2026 | 23.81% | 13.63 | |
| 15 Apr 2026 | 24.12% | 15.24 | |
| 30 Apr 2026 | 22.47% | 12.66 | 10-Q filed, results (8-K) |
| 15 May 2026 | 24.50% | 10.54 | |
| 29 May 2026 | 18.78% | 16.02 | |
| 15 Jun 2026 | 22.41% | 9.10 | |
| 30 Jun 2026 | 24.62% | 8.56 | |
| 15 Jul 2026 | 23.49% | 9.83 | |
| 31 Jul 2026 | 25.38% | 18.58 | |
| 14 Aug 2026 | 25.65% | 15.03 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 24.28% | 19.65 | |
| 15 Sep 2026 | 23.14% | 14.73 |
See also: Syndax Pharmaceuticals Inc's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.